MEGAN GARDNER: Open Payments
NPI 1932577871 · EAGAN, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 50 payments from 13 companies in 2025. Trend: 2023 $161 · 2024 $550 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $188 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| ABBVIE INC. | 7 | $138 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Exact Sciences Corporation | 4 | $68 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
Products named: VRAYLAR, Wegovy, FARXIGA, REXULTI, Cologuard Collection Kit, AIRSUPRA, TRELEGY ELLIPTA, Veozah.
Industry payments across MN — which companies pay providers there.
